Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      MDLifespan and Dr. Jill Carnahan Launch "Next Gen Mold Detox" Using Therapeutic Plasma Exchange


      News provided by

      MDLifespan

      Aug 04, 2025, 09:36 ET

      Share this article

      Share this article


      Dr Jill's MDLifespan Mold Protocol is the First Clinically Proven Therapeutic Plasma Exchange Detox to Remove up to 90% of Mold Toxins

      DENVER, Aug. 4, 2025 /PRNewswire/ -- MDLifespan (https://mdlifespan.com/ , the nation's first physician-led practice specializing exclusively in therapeutic plasma exchange (TPE) for toxin removal and regenerative wellness, today announced the launch of Dr. Jill's MDLifespan Mold PlasmaXchange Protocol, a groundbreaking mold detoxification protocol created in collaboration with nationally renowned mold toxicity expert Dr. Jill Carnahan.

      Continue Reading
      Dr. Jill Carnahan, widely recognized as the world-leading authority on mold toxicity, collaborated with MDLifespan to develop Dr. Jill's MDL Mold Protocol, integrating her extensive clinical expertise with MDLifespan's pioneering plasma-based detox technology.
      Dr. Jill Carnahan, widely recognized as the world-leading authority on mold toxicity, collaborated with MDLifespan to develop Dr. Jill's MDL Mold Protocol, integrating her extensive clinical expertise with MDLifespan's pioneering plasma-based detox technology.
      MDLifespan Mold PlasmaXchange Protocol Clinical results demonstrate this protocol removes up to 90% of mold toxins, significantly outperforming traditional treatments such as standalone TPE (~30% removal) or oral binders (~17% removal).
      MDLifespan Mold PlasmaXchange Protocol Clinical results demonstrate this protocol removes up to 90% of mold toxins, significantly outperforming traditional treatments such as standalone TPE (~30% removal) or oral binders (~17% removal).

      Clinical results demonstrate this protocol removes up to 90% of mold toxins, significantly outperforming traditional treatments such as standalone TPE (~30% removal) or oral binders (~17% removal).

      A New Solution for a Toxic Epidemic

      Millions of Americans suffer from chronic mold toxicity, experiencing debilitating symptoms such as brain fog, fatigue, joint pain, respiratory issues, depression, anxiety, and chronic inflammation.

      According to public health and building studies, nearly half of all U.S. homes and buildings show evidence of dampness or mold growth, placing millions at risk of chronic toxin exposure.

      Clinically Proven Mold Detox

      Dr. Jill's MDL Mold Protocol is a first-of-its-kind solution designed specifically for patients suffering from chronic mold toxicity—a widespread condition notoriously difficult to treat effectively. 

      "This protocol is transformative for patients suffering from mold-related illnesses," said Dr. Paul Savage, founder and CEO of MDLifespan. "Our partnership with Dr. Carnahan has produced the first solution clinically proven to dramatically reduce mold toxin levels—far better than any other method previously employed, enabling real recovery for patients with mold toxicity."

      Expert Collaboration for Effective Detoxification

      Dr. Jill Carnahan, widely recognized as the world-leading authority on mold toxicity, collaborated with MDLifespan to develop Dr. Jill's MDL Mold Protocol, integrating her extensive clinical expertise with MDLifespan's pioneering plasma-based detox technology. The protocol also features a specially formulated nutrient powder for daily use.

      This collaboration follows the heels of a recent study published in Medical Hypothesis, led by the founders of MDLifespan Dr. Paul Savage and Dr. Pamela W. Smith, on the combination of serial TPE with nutrient supplementation for toxin elimination.

      "I've spent years searching for truly effective solutions for my patients," said Dr. Carnahan. "The MDL Mold Protocol offers not just symptom relief, but deep cellular detoxification—addressing the root cause and allowing patients to reclaim their health."

      Dr. Jill's MDL Mold Protocol is now available nationwide to all MDLifespan locations, including Flatiron Functional Medicine, Dr. Carnahan's renowned Colorado-based clinic.

      About MDLifespan

      MDLifespan is a physician-led health tech and Public Benefit Corporation with a mission to eliminate the environmental toxins that cause chronic disease and inflammation, and to make America toxin-free again. MDLifespan offers patented, data-driven protocols for brain health, cardiovascular wellness, immune resilience, and mold detoxification through Therapeutic Plasma Exchange (TPE). Founded by Dr. Paul Savage, MDLifespan is dedicated to proactive, personalized care that addresses the root causes of illness.

      About Dr. Jill Carnahan

      Dr. Jill Carnahan, MD, ABIHM, is a leading expert in mold toxicity and the founder of Flatiron Functional Medicine in Boulder, Colorado. A survivor of both breast cancer and Crohn's disease, she brings personal resilience and deep clinical insight to patient care—helping individuals uncover the root causes of illness and restore health through personalized, integrative approaches. Board-certified in both Family Medicine and Integrative Holistic Medicine, Dr. Carnahan combines conventional diagnostics with cutting-edge lab testing, nutrition, and lifestyle interventions to treat chronic and complex conditions. Her award-winning documentary, Doctor/Patient chronicles her personal journey overcoming mold-related illness.

      Contact Information:
      Jessica Rafaeil
      404-936-0191
      [email protected]

      SOURCE MDLifespan

      Modal title

      Also from this source

      Advanced Serial Plasma Exchange Arrives in Beverly Hills as Los Angeles Faces Rising Environmental Health Concerns

      Advanced Serial Plasma Exchange Arrives in Beverly Hills as Los Angeles Faces Rising Environmental Health Concerns

      MDLifespan (www.mdlifespan.com), a physician-led medical technology company and Public Benefit Corporation, today announced the launch of its...

      MDLifespan and Cenegenics Partner to Expand Therapeutic Plasma Exchange Across the United States

      MDLifespan and Cenegenics Partner to Expand Therapeutic Plasma Exchange Across the United States

      MDLifespan (www.mdlifespan.com), a physician-led medical technology company and certified Public Benefit Corporation, announced a strategic...

      More Releases From This Source

      Explore

      Health Care & Hospitals

      Health Care & Hospitals

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      New Products & Services

      New Products & Services

      Clinical Trials & Medical Discoveries

      Clinical Trials & Medical Discoveries

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.